GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated June 1, 2023, serves as a notification to the market regarding the company's total voting rights and capital structure. The report is filed in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R. The data reflects the company's status as of May 31, 2023.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital and voting rights.
- Issued Share Capital: 4,312,058,959 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 217,068,169 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,094,990,790.
Material Changes
The filing text does not provide comparative data against prior periods to identify material changes in share capital or voting rights.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. Its sole purpose is to provide the denominator for shareholder notification calculations under FCA rules.
Key Facts for Investor Verification
- Verify the total number of voting rights (4,094,990,790) for compliance with FCA disclosure thresholds.
- Confirm the number of shares held in Treasury (217,068,169) to understand the difference between issued capital and voting rights.
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly earnings releases for financial performance.